Assessment of the Disease Severity and Treatment Patterns of Rheumatoid Arthritis in Eastern Europe, Middle East and North African Countries (P08167)

Merck Sharp & Dohme (MSD)

Status: Withdrawn

Conditions: Arthritis, Rheumatoid

Study type: Observational

Funder types: Industry

Identifiers

NCT01313871

P08167

Details and patient eligibility

About

The study will assess the disease severity and treatment patterns of rheumatoid arthritis in Eastern European, Middle Eastern, and North African countries.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria :

• Confirmed diagnosis of rheumatoid arthritis, preferably based upon criteria established by the American College of Rheumatology (ACR) 1987
• clinical signs & symptoms
• data obtained from previous laboratory and instrumental examination, which may include but is not limited to: Radiography, Blood tests
• Written informed consent, signed before participation in the study.

Exclusion Criteria :

• Refusal to participate in the study
• Age under 18 years

Trial design

0 participants in 1 patient group

All Participants

Description:

Adults with a confirmed diagnosis of rheumatoid arthritis